879 results on '"Kourtis, Athena P"'
Search Results
2. Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008–20: a national cohort study
3. Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi
4. A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
5. Crush: A Randomized Trial to Evaluate the Impact of a Mobile Health App on Adolescent Sexual Health
6. Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
7. HIV risk associated with serum medroxyprogesterone acetate (MPA) levels among women in East and southern Africa
8. An estimate of excess deaths among people with HIV during the coronavirus disease 2019 pandemic in the United States, 2020
9. Prevented perinatal HIV infections in the era of antiretroviral prophylaxis and treatment, United States, 1994–2020
10. Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy on Maternal Bone Mineral Density
11. Impact of the coronavirus disease 2019 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019–2021
12. Dr. Dawn K. Smith, in memoriam
13. Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial
14. Vital Signs : Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
15. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy
16. Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study
17. Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014–2019
18. Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential.
19. HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021
20. Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children : An Individual Pooled Analysis of African and Asian Studies
21. Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy
22. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial
23. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC–MS/MS
24. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women
25. Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010
26. HIV Services and Outcomes During the COVID-19 Pandemic--United States, 2019-2021
27. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus–Exposed, Uninfected Infants in Malawi: The BAN Study
28. Hepatitis B Virus (HBV) Load Response to 2 Antiviral Regimens, Tenofovir/Lamivudine and Lamivudine, in HIV/ HBV-Coinfected Pregnant Women in Guangxi, China: The Tenofovir in Pregnancy (TiP) Study
29. Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study
30. Identification of pregnancies and their outcomes in healthcare claims data, 2008–2019: An algorithm
31. Achieving Elimination of Perinatal HIV in the United States
32. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi
33. Antiretroviral Drugs During Breastfeeding for the Prevention of Postnatal Transmission of HIV-1
34. The Future of Breastfeeding in the Face of HIV-1 Infection: Science and Policy
35. B Lymphocyte-Derived Humoral Immune Defenses in Breast Milk Transmission of the HIV-1
36. Cellular Immunity in Breast Milk: Implications for Postnatal Transmission of HIV-1 to the Infant
37. Breastfeeding and Transmission of HIV-1: Epidemiology and Global Magnitude
38. Factors Associated with Contraceptive Use Differ between Younger and Older African-American Female Adolescents
39. Cytomegalovirus Infection in Human Immunodeficiency Virus (HIV)–Exposed and HIV-Infected Infants: A Systematic Review
40. Recent Biomarker-Confirmed Unprotected Vaginal Sex, But Not Self-reported Unprotected Sex, Is Associated With Recurrent Bacterial Vaginosis
41. Use of Dual Methods for Protection from Unintended Pregnancy and Sexually Transmitted Diseases in Adolescent African American Women
42. Effects of initiating a contraceptive implant on subsequent condom use: A randomized controlled trial
43. Predictors of Perinatal HIV Transmission Among Women Without Prior Antiretroviral Therapy in a Resource-Limited Setting: The BAN Study
44. Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial
45. HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa
46. Hepatitis B Virus
47. 2gether: A Clinic-Based Intervention to Increase Dual Protection from Sexually Transmitted Infections and Pregnancy in Young African American Females
48. Trends in contraceptive use according to HIV status among privately insured women in the United States
49. Tenofovir Disoproxil Fumarate Use during Pregnancy and Infant Bone Health: the Tenofovir in Pregnancy Pilot Study
50. Full-Term Small-for-Gestational-Age Newborns in the U.S.: Characteristics, Trends, and Morbidity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.